MedTrace Logo

Efficacy and Safety of Industrially Prepared 3 Chamber Bag Parenteral Nutrition for Premature Infant

NCT04168749 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-11-19

No results posted yet for this study

Summary

This study was designed to evaluate whether industrially prepared standardizing total parenteral nutrition is at least non-inferior to compounded TPN and provides nutritional intakes according to the new guidelines and provides the expected weight gain in preterm babies with a birth weight between 1250 and 2000g admitted in our NICU between 2015 \& 2018

Conditions

  • Weight Gain
  • Intravenous Nutrition Adverse Reaction
  • Premature

Interventions

COMBINATION_PRODUCT

Numeta G13

10 days

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Centre Hospitalier Universitaire de Tivoli

    lead OTHER

Principal Investigators

  • Geneviève Malfilâtre · Centre Hospitalier Universitaire de Tivoli

Eligibility

Min Age
1 Day
Max Age
15 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-15
Primary Completion
2020-03-30
Completion
2020-05-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04168749 on ClinicalTrials.gov